<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7491497/table_3" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 3</label>
  <p>Clinical studies of rosemary and the active constituents on neuropathic pain, stress and anxiety</p>
 </caption>
 <thead>
  <tr>
   <th style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1" id="0-0-.">Subjects</th>
   <th style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1" id="0-1-.">Type of extract, constituents/ doses/ Time of exposure</th>
   <th style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1" id="0-2-.">Endpoints </th>
   <th style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1" id="0-3-.">Reference</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Rats</td>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Alcoholic extract; (100, 200, and 400mg/kg); 14 days</td>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">- All three mentioned doses of rosemary extract reduced neuropathic behavioral changes as compared with CCI animals that received the vehicle. 
    <br/>- Rosemary extract, 400mg/kg notably declined the levels of Bax, cleaved caspases 3 and 9, Iba1, TNF-Î±, iNOS and TLR4 in comparison with vehicle-treated CCI animals. 
   </td>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">( 
    <a rid="B84" ref-type="bibr">84</a>) 
   </td>
  </tr>
  <tr>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Mice </td>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Rosmanol, cirsimaritin and salvigenin; (50-200 mg/kg)</td>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">- They elicited anxiolytic, antinociceptive, and antidepressant properties. 
    <br/>- These compounds were indicated to possess biphasic modulation of GABA 
    <sub>A</sub> receptors. 
   </td>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">( 
    <a rid="B95" ref-type="bibr">95</a>) 
   </td>
  </tr>
  <tr>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Mice</td>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">essential oil</td>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">- Inhalation of rosemary essential oil considerably minified the immobility time of mice and serum corticosterone level, accompanied by increased brain dopamine level.</td>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">( 
    <a rid="B121" ref-type="bibr">121</a>) 
   </td>
  </tr>
  <tr>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Mice</td>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Rosemary tea; (2% w/w); 4 weeks</td>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">- Cholinesterase isoforms activity was lowered in the brain of rosemary treated group.</td>
   <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">( 
    <a rid="B124" ref-type="bibr">124</a>) 
   </td>
  </tr>
 </tbody>
</table>
